Comparison of Minimum Flow and Low Flow Desflurane Anesthesia in Robotic Assisted Laparoscopic Abdominal Surgery
Launched by ANKARA CITY HOSPITAL BILKENT · Jul 23, 2024
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to give anesthesia during robotic-assisted abdominal surgery. Anesthesia is the medicine that helps keep patients comfortable and pain-free during surgery. The study will compare "low flow" anesthesia, which uses a fresh gas flow of 1 liter per minute, with "minimum flow" anesthesia, which uses 0.5 liters per minute. Researchers want to see how these two methods affect patients' heart and breathing during surgery, as well as how much of the anesthetic gas and absorbent material they use.
To participate in this trial, patients must be scheduled for robotic-assisted abdominal surgery. However, those with serious heart, lung, liver, kidney, or mental health issues, as well as those who are anxious or depressed, may not be eligible. The trial is not yet recruiting participants, but once it starts, volunteers will receive one of the two types of anesthesia and will be monitored closely during their surgery. This study aims to find the safest and most efficient way to provide anesthesia for patients undergoing this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing robotic-assisted abdominal surgery
- Exclusion Criteria:
- • serious cardiac, respiratory, hepatic, renal, or mental disorders;
- • hearing problems;
- • anxiety, depression, or other psychiatric conditions;
- • patient's request to leave the study
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Betül Güven Aytaç
Principal Investigator
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported